Home Polysomnography in Children With Autism Spectrum Disorder: A Prospective Observational Study.

This was an observational study — researchers watched what happened rather than assigning treatments. It can show that two things happen together, but it cannot show that one caused the other.

It involved only 20 people. Without random assignment, a group this small makes it especially easy for something other than what was studied to explain the difference researchers saw. Treat this as a very early signal rather than an answer.

The abstract does not include a conclusions section, so this page does not state what the researchers concluded.

This record does not state:

• how long the study ran

This is a plain-language summary of one paper's abstract, not medical advice. Talk to your child's clinician before changing anything.

Journal: Journal of sleep research

Year: 2026

Design: Observational Study

Participants: 20

Age range: 6-12 years

Intervention: neurodevelopmental condition

Co-occurring conditions: Sleep Wake Disorders

Authors: Uchenna Ezedinma, Scott Burgess, Janet Greenhill, Jyoti Singh, Evan Jones, Andrew Ladhams, Gary Campbell, Shauna Fjaagesund, Piotr Swierkowski, Alexandra Metse, Terri Downer, Florin Oprescu

This prospective observational study reports on the feasibility and adequacy of Level 2 polysomnography involving children with autism spectrum disorder during an interventional-randomised controlled trial. Multiple level 2 polysomnographic studies were performed using Nox-A1 devices worn between October 2023 and September 2024. Study feasibility was determined by the child's compliance and primary caregiver report, while signal quality (key channels present for at least 90% of sleep time) was used to define study adequacy. A cost analysis was also conducted. Twenty children (6-12 years, 9.1 + 1.55 years; 16 males) with autism spectrum disorder (level 2) and reported sleep difficulties participated in the study. Eighty (89%) of 90 polysomnographic studies were feasible. All infeasible studies, except one, were unrelated to the study. Seventy-four (93%) of the eighty studies resulted in adequate study quality. Most (n = 6, 7%) inadequate studies were due to electroencephalogram signal artefact/absence. The participants did not have a sleep disorder requiring medical attention. The cost of a study was estimated at $AUD 258. The study indicates the feasibility, adequacy, and cost-effectiveness of level 2 polysomnography in evaluating sleep outcomes in children with autism spectrum disorder during an interventional randomised controlled trial. This preliminary study provides valuable insights into the field of paediatric sleep medicine. Repeat studies of this method using diverse and larger sample sizes are warranted.

Journal of sleep research, 2026

PMID 41392642

DOI 10.1111/jsr.70265

This record was extracted from the paper's PubMed abstract and metadata. Full-text methods and risk-of-bias details were not reviewed.